Pretzelmaker to Give Away 65,000 Pretzels for LLS

A national retail pretzel maker aims to make an impact against blood cancers on National Pretzel Day, April 26.

In support of the Leukemia & Lymphoma Society, gourmet pretzel shop Pretzelmaker is determined to give away 65,000 pretzels – the most in the company's history – while raising money and awareness for the LLS. Last year, the company gave away 40,000 pretzels.

On Saturday, April 26, customers at Pretzelmaker locations will be encouraged, not obligated, to make an in-kind donation to the LLS. If it can achieve its goal of giving away 65,000 pretzels, it will make a corporate contribution to the LLS as well.

Online donations can be made by visiting its Light the Night corporate management site here.

Company uses major selling day to help LLS

"National Pretzel Day is our biggest and most exciting day of the year," said David Smith, Pretzelmaker's vice president. "Because of the excitement and exposure surrounding our annual pretzel giveaway, we decided to introduce customers to our charity of choice, the Leukemia & Lymphoma Society. We hope our customers enjoy their free pretzel and consider making a donation to the organization that brightens the lives of cancer patients and their families."

"National Pretzel Day is always a momentous occasion, but this year even more so," Smith continued. "We invite our customers to visit and help us reach our goal of giving away 65,000 free pretzels in support of The Leukemia & Lymphoma Society."

For more information, you can visit Pretzelmaker's website here.

Source: Digital Journal

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap